You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Management of Small Cell Lung Cancer

  • Authors: Ticiana Leal, MD; Jennifer W. Carlisle, MD; Aditya Juloori, MD; Misty Dawn Shields, MD, PhD
  • CME / ABIM MOC / CE Released: 3/31/2023
  • Valid for credit through: 3/31/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    Nurses - 0.50 ANCC Contact Hour(s) (0.5 contact hours are in the area of pharmacology)

    Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, pulmonologists, radiologists (including radiation oncologists), nurses/nurse practitioners (NPs), physician assistants (PAs), and pharmacists.

The goal of this activity is for the learner to be better able to understand the roles of the interprofessional team in tailoring the management of patients with small cell lung cancer (SCLC).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical trial data evaluating regimens used to treat patients with SCLC
    • Emergence of novel therapies for SCLC
  • Have greater competence related to
    • Tailoring therapy for patients with SCLC
  • Demonstrate greater confidence in their ability to
    • Leverage the use of an interprofessional team to optimize outcomes in patients with SCLC


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Session Chair

  • Ticiana Leal, MD

    Associate Professor of Medicine
    Director, Thoracic Medical Oncology Program
    Department of Hematology and Medical Oncology
    Winship Cancer Institute
    Emory University School of Medicine
    Atlanta, Georgia

    Disclosures

    The opinions expressed are those of Dr Leal and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Leal's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare. 

    Ticiana Leal, MD, has the following relevant financial relationships:
    Consultant or advisor for: Amgen, Inc.; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Eisai, Inc.; EMD Serono, Inc.; Genentech; Janssen; Jazz Pharmaceuticals, Inc.; Lilly; Merck; Mirati Therapeutics, Inc.; Novocure; Roche; Takeda

Faculty

  • Jennifer W. Carlisle, MD

    Assistant Professor of Medicine
    Winship Cancer Institute
    Emory University School of Medicine
    Atlanta, Georgia

    Disclosures

    The opinions expressed are those of Dr Carlisle and do not necessarily reflect the views of Emory University or Emory Healthcare. Dr Carlisle's participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

    Jennifer W. Carlisle, MD, has no relevant financial relationships.

  • Aditya Juloori, MD

    Assistant Professor
    Department of Radiation and Cellular Oncology
    University of Chicago
    Chicago, Illinois

    Disclosures

    Aditya Juloori, MD, has the following relevant financial relationships:
    Consultant or advisor for: Aqualung Therapeutics; GE Healthcare; Isoray
    Research funding from: AstraZeneca

  • Misty Dawn Shields, MD, PhD

    Assistant Professor of Clinical Medicine
    Division of Hematology/Oncology
    Associate Member, Experimental and Developmental Therapeutics
    Indiana University School of Medicine
    Indiana University Health Physicians
    Indianapolis, Indiana

    Disclosures

    Misty Dawn Shields, MD, PhD, has no relevant financial relationships.

Editor

  • John Churchwell, PhD

    Medical Education Director, Medscape, LLC

    Disclosures

    John Churchwell, PhD, has the following relevant financial relationships:
    Formerly employed by an ineligible company: Medtronic, Inc.  

Compliance Reviewer/Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    The European Union of Medical Specialists (UEMS)-European Accreditation Council for Continuing Medical Education (EACCME) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC) should contact the UEMS (www.uems.eu).

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

    For Pharmacists

  • Medscape, LLC designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number JA0007105-0000-23-084-H01-P).

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Management of Small Cell Lung Cancer

Authors: Ticiana Leal, MD; Jennifer W. Carlisle, MD; Aditya Juloori, MD; Misty Dawn Shields, MD, PhDFaculty and Disclosures

CME / ABIM MOC / CE Released: 3/31/2023

Valid for credit through: 3/31/2024

processing....

Contents of This CME Activity

All sections of this activity are required for credit.

Standard Management of Small Cell Lung Cancer

Find out the latest about standard management of SCLC in this informative presentation.
Jennifer W. Carlisle, MD

The Evolving Role of Radiation in the Treatment of Small Cell Lung Cancer

Get ready to take your clinical skills to the next level with this discussion focused on the evolving landscape of radiation treatment in SCLC.
Aditya Juloori, MD

Novel Approaches to Small Cell Lung Cancer

Keep pace with rapidly changing strategies for treatment of SCLC with this succinct presentation.
Misty Dawn Shields, MD, PhD
 

Learning Feedback Questions

Please answer these questions to complement your learning experience.

  • Print